Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective randomized phase II trial for the treatment of patients with advanced hormone refractory prostate cancer using LHRH analogues and somatostatin analogues, as well as taking into account the expression of neuroendocrine Androgen receptor status [Prospektive randomisierte Phase II Studie zur Behandlung von Patienten mit fortgeschrittenem hormonrefraktären Prostatakarzinom mittels LHRH-Analoga und Somatostatin-Analoga unter Berücksichtigung der neuroendokrinen Expression sowie des Androgenrezeptorstatus]

Next Previous
X
Search
Trial Profile

Prospective randomized phase II trial for the treatment of patients with advanced hormone refractory prostate cancer using LHRH analogues and somatostatin analogues, as well as taking into account the expression of neuroendocrine Androgen receptor status [Prospektive randomisierte Phase II Studie zur Behandlung von Patienten mit fortgeschrittenem hormonrefraktären Prostatakarzinom mittels LHRH-Analoga und Somatostatin-Analoga unter Berücksichtigung der neuroendokrinen Expression sowie des Androgenrezeptorstatus]

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 May 2012

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lanreotide (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms Soma47

    • Most Recent Events

    • 03 May 2012 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top